help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on October 25, 2007, doi:10.1164/rccm.200612-1890OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200612-1890OCv1
177/2/208    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, Y.-M.
Right arrow Articles by Dakhama, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, Y.-M.
Right arrow Articles by Dakhama, A.
American Journal of Respiratory and Critical Care Medicine Vol 177. pp. 208-218, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200612-1890OC


Original Article

IFN-{gamma} Production during Initial Infection Determines the Outcome of Reinfection with Respiratory Syncytial Virus

Young-Mok Lee1, Nobuaki Miyahara1, Katsuyuki Takeda1, John Prpich1, Anita Oh1, Annette Balhorn1, Anthony Joetham1, Erwin W. Gelfand1 and Azzeddine Dakhama1

1 Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado

Correspondence and requests for reprints should be addressed to Azzeddine Dakhama, Ph.D., Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206. E-mail: dakhamaa{at}njc.org

Rationale: Severe respiratory syncytial virus (RSV) bronchiolitis has been associated with deficient IFN-{gamma} production in humans, but the role of this cytokine in determining the outcome of reinfection is unknown.

Objectives: To define the role of IFN-{gamma} in the development of RSV-mediated airway hyperresponsiveness (AHR) and lung histopathology in mice.

Methods: Wild-type (WT) and IFN-{gamma} knockout mice were infected with RSV in the newborn or weaning stages and reinfected 5 weeks later. Airway responses were assessed on Day 6 after the primary or secondary infection.

Measurements and Main Results: Both WT and IFN-{gamma} knockout mice developed similar levels of AHR and airway inflammation after primary infection. After reinfection, IFN-{gamma} knockout mice, but not WT mice, developed AHR, airway eosinophilia, and mucus hyperproduction. Intranasal administration of IFN-{gamma} during primary infection but not during reinfection prevented the development of these altered airway responses on reinfection in IFN-{gamma} knockout mice. Adoptive transfer of WT T cells into IFN-{gamma} knockout mice before primary infection restored IFN-{gamma} production in the lungs and prevented the development of altered airway responses on reinfection. Treatment of mice with IFN-{gamma} during primary neonatal infection prevented the enhancement of AHR and the development of airway eosinophilia and mucus hyperproduction on reinfection.

Conclusions: IFN-{gamma} production during primary RSV infection is critical to the development of protection against AHR and lung histopathology on reinfection. Provision of IFN-{gamma} during primary infection in infancy may be a potential therapeutic approach to alter the course of RSV-mediated long-term sequelae.

Key Words: respiratory syncytial virus • interferon-{gamma} • asthma • airway hyperresponsiveness • mice


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Deficient IFN-{gamma} production has been associated with respiratory syncytial virus (RSV) bronchiolitis. However, the role of IFN-{gamma} in determining the outcome of reinfection with RSV remains unknown.

What This Study Adds to the Field
IFN-{gamma} plays a critical role during initial infection that determines the outcome of reinfection with RSV. Provision of IFN-{gamma} may interfere with the development of altered airway responses to reinfection in children.

 



This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
S. S. Mohapatra and S. Boyapalle
Epidemiologic, Experimental, and Clinical Links between Respiratory Syncytial Virus Infection and Asthma
Clin. Microbiol. Rev., July 1, 2008; 21(3): 495 - 504.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. S. Tregoning, Y. Yamaguchi, J. Harker, B. Wang, and P. J. M. Openshaw
The Role of T Cells in the Enhancement of Respiratory Syncytial Virus Infection Severity during Adult Reinfection of Neonatally Sensitized Mice
J. Virol., April 15, 2008; 82(8): 4115 - 4124.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008